Rochester General Hospital
15
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
26.7%
4 terminated/withdrawn out of 15 trials
60.0%
-26.5% vs industry average
13%
2 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Safety and Efficacy of wSp Vaccine in Young Children
Role: collaborator
Dynamic Change and Immune Response to Nasopharyngeal Carriage and Acute Otitis Media Pathogens
Role: lead
Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.
Role: lead
Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention
Role: lead
Mechlorethamine Induced Contact Dermatitis Avoidance Study
Role: collaborator
Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
Role: lead
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
Role: lead
Oral Vancomycin for Preventing Clostridium Difficile Recurrence
Role: lead
Humoral Immunodeficiency With Rituximab and Therapy With Subcutaneous Ig
Role: lead
Dupilumab for Aspirin-exacerbated Respiratory Disease
Role: lead
Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig
Role: lead
The Capillary Index Score Trial
Role: collaborator
Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium
Role: lead
Comparing the Cost Savings Potential of Orogastric Tubes in Laparoscopic Sleeve Gastrectomy
Role: collaborator
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
Role: collaborator
All 15 trials loaded